VICTOR M PLAVNER
Allopathic & Osteopathic Physicians|Family Medicine ARNOLD, MD NPI 1104818004
Browse related groups: Allopathic & Osteopathic Physicians|Family Medicine MD EISAI INC. All categories
General Payments — all program years on this page
$15,993.15
- Category: General Payments
- Program years: PY2018–2024
- Record count: 712
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $3,901.23 across 107 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $2,661.23 | 106 |
| Consulting Fee | $1,240.00 | 1 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| EISAI INC. | $1,240.00 | 1 |
| ABBVIE INC. | $643.10 | 20 |
| Acerta Pharma LLC | $291.31 | 6 |
| Novo Nordisk AS | $275.78 | 15 |
| GlaxoSmithKline, LLC. | $202.70 | 9 |
| Lilly USA, LLC | $201.54 | 14 |
| PFIZER INC. | $169.93 | 9 |
| Bayer HealthCare Pharmaceuticals Inc. | $151.15 | 4 |
| Janssen Biotech, Inc. | $114.83 | 1 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $100.68 | 6 |
| Exact Sciences Corporation | $84.59 | 3 |
| Astellas Pharma US Inc | $73.44 | 4 |
| Merck Sharp & Dohme Corporation | $44.69 | 2 |
| Abbott Laboratories | $42.60 | 2 |
| Silk Road Medical, Inc. | $40.71 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $38.84 | 2 |
| Microtransponder, Inc. | $33.89 | 1 |
| Corium, Inc. | $29.41 | 1 |
| Otsuka America Pharmaceutical, Inc. | $28.73 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $25.48 | 1 |
| Gilead Sciences, Inc. | $19.55 | 1 |
| WATERMARK MEDICAL, INC. | $17.36 | 1 |
| Amgen Inc. | $15.99 | 1 |
| Medtronic, Inc. | $14.93 | 1 |
By program year
Records — PY2024 (107)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.